IGF-1 LR3: 0.1mg & 1mg Vials

IGF-1 LR3 (Insulin-like Growth Factor-1 Long R3) is a modified IGF-1 analogue with reduced IGFBP binding affinity studied in Australian preclinical research for enhanced potency in cell proliferation and differentiation assays. Australian laboratories investigate myoblast proliferation, tissue regeneration signalling, and anabolic pathway activation in controlled research models.

No. IGF-1 LR3 is strictly for laboratory research only. It is not intended for human consumption, therapeutic application, performance enhancement, or veterinary use. All Australian purchasers must confirm legitimate research intent.

Refer to product documentation for specific storage guidance. In general, store lyophilised IGF-1 LR3 in a freezer. After reconstitution with bacteriostatic water, refrigerate and follow the usage timeframe in the product documentation. Protect from light, moisture, and repeated freeze-thaw cycles. Always handle using sterile technique in a controlled laboratory environment.

Availability varies by product and batch. Where independent testing is complete, batch-specific Certificates of Analysis are available on request. All documentation sources are clearly labelled.

Dispatched within 1–3 business days from our international fulfilment partners in discrete, temperature-protected packaging. Estimated delivery is 5–9 days from order, processing included, express with a carrier tracking number Australia-wide. Free over $700 AUD. Every order ships express with a carrier tracking number emailed on dispatch. Trial vials are faster: they ship from domestic stock via Australia Post Express, same-day dispatch before 3 PM AEST, arriving in 2–3 business days.